Brief: Chinook Therapeutics Inc Files Prospectus Supplement For Potential Offering Of Up To $150 Million Of Common Stock
10/11/2022 22:26
Nov 10 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS INC FILES PROSPECTUS SUPPLEMENT FOR
POTENTIAL OFFERING OF UP TO $150 MILLION OF COMMON STOCK
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc